Avalanche of direct-to-consumer drug marketing brings new questions.
Open Access
- 21 June 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 92 (12) , 964-967
- https://doi.org/10.1093/jnci/92.12.964
Abstract
Regulation of broadcast advertising for prescription drugs began in 1997 when the U.S. Food and Drug Administration issued draft guidelines, which were made final last August. The resulting deluge of advertising—not just on television, but on bus shelters and in magazine, newspaper, and radio ads—has prompted heated opinions from all sides of the debate.Keywords
This publication has 0 references indexed in Scilit: